Surgical therapy for sudden cardiac death in children

Robert D B Jaquiss1, James S Tweddell, S Bert Litwin

  • 1Division of Cardiothoracic Surgery, Medical College of Wisconsin, 9000 West Wisconsin Avenue, MS. 715, Milwaukee, WI 53226, USA. rjaquiss@chw.org

Insights

Sudden cardiac death in children requires tailored treatment based on the cause. Therapy ranges from internal defibrillator implantation to surgical repair of congenital heart defects.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Sudden Cardiac Death Etiologies

Background:

  • Sudden cardiac death (SCD) in children presents diverse etiologies.
  • Effective prophylaxis and treatment necessitate individualized approaches.

Purpose of the Study:

  • To outline tailored therapeutic strategies for preventing sudden cardiac death in pediatric populations.
  • To address management variations based on the presence and history of congenital heart disease.

Main Methods:

  • Review of current therapeutic interventions for pediatric sudden cardiac death.
  • Categorization of treatment modalities based on patient subgroups: no congenital heart disease, unrepaired congenital heart disease, and post-surgical congenital heart disease.

Main Results:

  • For children without congenital heart disease, internal defibrillator implantation is a primary surgical option, adapted for pediatric size.
  • In cases of unrepaired congenital heart disease, surgical correction of the anomaly is the main therapeutic approach.
  • For those with a history of congenital heart disease surgery, treatment involves addressing residual defects, potentially combined with antiarrhythmia procedures or defibrillator implantation.

Conclusions:

  • Treatment for pediatric sudden cardiac death must be individualized to the underlying etiology.
  • Surgical interventions, including defibrillator implantation and anomaly repair, are key components of SCD management in children.
  • Management strategies differ significantly for patients with and without congenital heart disease, as well as those with prior surgical interventions.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...